The Department of Anaesthesiology and Intensive Care Medicine, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Blå Stråket 5, 413 45, Gothenburg, Sweden.
The Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Neurocrit Care. 2018 Dec;29(3):404-412. doi: 10.1007/s12028-018-0558-0.
Cardiac complications frequently occur after subarachnoid hemorrhage (SAH) and are associated with an increased risk of neurological complications and poor outcomes. The aim of this study was to evaluate the impact of acute cardiac complications after SAH on long-term mortality and cardiovascular events.
All patients admitted to our Neuro intensive care unit with verified SAH from January 2010 to April 2015, and electrocardiogram, echocardiogram, and troponin T or NTproBNP data obtained within 72 h of admission were included in the study. Mortality data were obtained from the Swedish population register. Data regarding cause of death and hospitalization for cardiovascular events were obtained from the Swedish Board of Health and Welfare.
A total of 455 patients were included in the study analysis. There were 102 deaths during the study period. Cardiac troponin release (HR 1.08, CI 1.02-1.15 per 100 ng/l, p = 0.019), NTproBNP (HR 1.05, CI 1.01-1.09 per 1000 ng/l, p = 0.018), and ST-T abnormalities (HR 1.53, CI 1.02-2.29, p = 0.040) were independently associated with an increased risk of death. However, these associations were significant only during the first 3 months after the hemorrhage. Cardiac events were observed in 25 patients, and cerebrovascular events were observed in 62 patients during the study period. ST-T abnormalities were independently associated with an increased risk of cardiac events (HR 5.52, CI 2.07-14.7, p < 0.001), and stress cardiomyopathy was independently associated with an increased risk of cerebrovascular events (HR 3.65, CI 1.55-8.58, p = 0.003).
Cardiac complications after SAH are associated with an increased risk of short-term death. Patients with electrocardiogram abnormalities and stress cardiomyopathy need appropriate follow-up for the identification of cardiac disease or risk factors for cardiovascular disease.
蛛网膜下腔出血(SAH)后常发生心脏并发症,与神经并发症和不良预后风险增加相关。本研究旨在评估 SAH 后急性心脏并发症对长期死亡率和心血管事件的影响。
纳入 2010 年 1 月至 2015 年 4 月期间入住我院神经重症监护病房且证实为 SAH 的所有患者,并在入院后 72 小时内获得心电图、超声心动图和肌钙蛋白 T 或 NTproBNP 数据。死亡率数据从瑞典人口登记处获得。心血管事件住院和死亡原因的数据从瑞典健康与福利委员会获得。
共有 455 例患者纳入研究分析。研究期间共有 102 例死亡。肌钙蛋白释放(每增加 100ng/L,HR 1.08,95%CI 1.02-1.15,p=0.019)、NTproBNP(每增加 1000ng/L,HR 1.05,95%CI 1.01-1.09,p=0.018)和 ST-T 异常(HR 1.53,95%CI 1.02-2.29,p=0.040)与死亡风险增加独立相关。然而,这些关联仅在出血后 3 个月内具有显著性。研究期间,25 例患者发生心脏事件,62 例患者发生脑血管事件。心电图异常与心脏事件风险增加独立相关(HR 5.52,95%CI 2.07-14.7,p<0.001),应激性心肌病与脑血管事件风险增加独立相关(HR 3.65,95%CI 1.55-8.58,p=0.003)。
SAH 后心脏并发症与短期死亡风险增加相关。心电图异常和应激性心肌病患者需要进行适当的随访,以识别心脏疾病或心血管疾病的危险因素。